Self URI: This article is available from https://www.sapd.es/revista/2024/47/2/07
Fecha de recepción: 06 Marzo 2024
Fecha de aceptación: 19 Mayo 2024
Fecha de publicación: 02 Julio 2024
M Lecuona Muñoz
Virgen de las Nieves University Hospital. Granada.
I Fernández García
E López González
C Tendero Peinado
E Redondo Cerezo
Gastrointestinal stromal tumors (GISTs), constituting digestive neoplasms, typically have a favorable prognosis, although occasional distant extension can occur. The main prognostic factors associated with GISTs are described as lesion size and the number of mitoses per field. These lesions primarily metastasize to the liver, omentum, and peritoneum, with lymphatic dissemination being exceptionally rare. Although the presence of lymph node involvement has been identified as an independent predictor of mortality, since it is an infrequent finding, further studies are needed to understand its prognostic and therapeutic implications. This clinical case describes the approach to a 75-year-old patient with no significant medical history presenting with gastric GIST, who notably had multiple tumor-associated lymph nodes on staging studies, requiring treatment with Imatinib.
Keywords: GIST, metastases, adenopathy.
Tanto si ha olvidado su contraseña, como si se ha bloqueado por intentos erróneos de conexión deberá:solicitar nueva contraseña